From: CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer
Characteristics | Value |
---|---|
Age (years) | 48.9 ± 1.55 |
Lymph node status | |
 Free | 29 (55.77%) |
 Involved | 23 (44.23%) |
 N0 | 15 (28.85%) |
 N1 | 24 (46.15%) |
 N2 | 9 (17.31%) |
 N3 | 4 (7.69%) |
Stage | |
 I | 9 (17.31%) |
 II | 29 (55.77%) |
 III | 14 (26.92%) |
Tumor size | |
 T1 (≤2) | 20 (41.66%) |
 T2 (2–5) | 28 (58.33%) |
 Unreported | 4 |
Tumor type | |
 Invasive ductal carcinoma (IDC) | 41 (82.00%) |
 Invasive lobular carcinoma (ILC) | 3 (6.00%) |
 Invasive medullary carcinoma (IMC) | 4 (8.00%) |
 Mixed IDC and ILC | 2 (4.00%) |
 Unreported | 2 |
Histological grade | |
 Well differentiated (I) | 5 (11.63%) |
 Moderately differentiated (II) | 27 (62.79%) |
 Poorly differentiated (III) | 11 (25.58%) |
 Unreported | 9 |
Estrogen receptor (ER) | |
 Negative | 37 (82.22%) |
 Positive | 8 (17.77%) |
 Unreported | 7 |
Progesterone receptor (PR) | |
 Negative | 11 (25.58%) |
 Positive | 32 (74.42%) |
 Unreported | 9 |
Her2 expression | |
 Negative | 30 (58.82%) |
 Positive | 15 (29.41%) |
 Equivocal | 6 (11.76%) |
 Unreported | 1 |
Invasion | |
Lymphatic invasion | |
 Negative | 11 (21.57%) |
 Positive | 40 (78.43%) |
 Unreported | 1 |
Vascular invasion | |
 Negative | 11 (21.57%) |
 Positive | 40 (78.43%) |
 Unreported | 1 |
Perineural invasion | |
 Negative | 5 (9.80%) |
 Positive | 46 (90.20%) |
 Unreported | 2 |